From your experience scaling from an RCT to more than 7,000 clinics, what evidence would you want to see before investing in a smaller Nigerian organisation proposing a community-based intervention—strong outcome data, operational capacity, cost-effectiveness, government relationships, or something else?
As New Incentives explores whether its model can work in lower-density or differently constrained settings, what characteristics would you look for in a local Nigerian organisation interested in serving as an implementation or pilot partner? Would you consider partnering with community-based health organisations to test adaptations of the model in underserved communities or displaced populations?
From your experience scaling from an RCT to more than 7,000 clinics, what evidence would you want to see before investing in a smaller Nigerian organisation proposing a community-based intervention—strong outcome data, operational capacity, cost-effectiveness, government relationships, or something else?
As New Incentives explores whether its model can work in lower-density or differently constrained settings, what characteristics would you look for in a local Nigerian organisation interested in serving as an implementation or pilot partner? Would you consider partnering with community-based health organisations to test adaptations of the model in underserved communities or displaced populations?